2026³â 03¿ù 20ÀÏ ±Ý¿äÀÏ

 

´º½º±×·ì
ÀÚµ¿Â÷°æÁ¦¿¬±¸¼Ò

 

 

ÀÚµ¿Â÷´º½º > Science & Technology


X-ray Leader XAVIS Expands Globally Into Semiconductor, Food Sectors After Inter Battery 2026 Success

Recognized for the world¡¯s first Dual-Inlet high-speed 3D CT inspection technology based on ¡®Rotating Optics¡¯.
´º½ºÀÏÀÚ: 2026-03-07

SEONGNAM -- XAVIS (KOSDAQ 254120) (CEO, Kim Hyeong-Cheol), a South Korean leader in automated X-ray inspection technology, announced that it has won the “3rd Inter Battery Awards” held at Inter Battery 2026—Korea's largest exhibition dedicated to the secondary battery industry.

This award recognizes XAVIS's Dual-Inlet high-speed 3D CT (computed tomography) battery inspection equipment, featuring its proprietary ‘Rotating Optics’ technology, for its excellence across five evaluation criteria: technological superiority, innovation, marketability, contribution to industrial development, and discourse relevance.

XAVIS's rotating optical system-based 3D CT inspection equipment enables high-speed, precise inspection of internal battery components like electrode alignment, electrode overhang, etc. It is establishing itself as an essential quality inspection solution for mass production lines at global secondary battery manufacturers. It is particularly recognized for maximizing inspection accuracy even during high-speed imaging by incorporating AI-based image quality enhancement technology.

The Inter Battery Awards is the official award program of Inter Battery, Korea‘s largest specialized secondary battery exhibition hosted by the Ministry of Trade, Industry and Resources and the Korea Battery Industry Association. It selects and honors innovative technologies and products that advance the battery industry. This year’s Inter Battery 2026 is expected to attract over 690 participating companies, including global battery giants like Samsung SDI, LG Energy Solution, and SK On, with more than 75,000 visitors anticipated.

XAVIS CEO Kim Hyeong-Cheol said, “The latest achievement recognizes XAVIS' technological prowess, honed through over 20 years of dedicated X-ray inspection technology development, both domestically and internationally.” He added, “We will continue to supply world-class battery inspection solutions in step with the explosive growth of the global secondary battery market, helping enhance the global competitiveness and safety of Korea’s battery industry.”

XAVIS is expanding its business domains beyond battery inspection equipment into various industrial sectors. In the food foreign object inspection equipment segment, it is actively responding to global food safety inspection demands by accelerating its entry into overseas markets. Furthermore, in the semiconductor sector, it is supplying TGV (Through Glass Via) inspection equipment — a core next-generation packaging technology—to major domestic research institutions, positioning itself to lead the advanced semiconductor inspection market. In the first half of the year, it plans to launch 3D AXI (Automated X-ray Inspection) equipment, poised to revolutionize the SMT/PCB market.

XAVIS said that it is accelerating its leap beyond equipment manufacturing to become a total solutions provider, which includes launching paid industrial X-ray inspection services and initiating paid Nano CT imaging services after nine years of R&D. The company plans to grow into the global No. 1 X-ray inspection solutions company across all business areas: secondary batteries, semiconductors, SMT/PCB, and food.



Ground Investigation for Civil Infrastructure Gets More Robust With Integration of Lab and Field Geotechnical Data
ChipAgents Raises $74M to Scale an Agentic AI Platform to Accelerate Chip Design
YolTech Therapeutics Announces Positive Interim Data on YOLT-202 for the Treatment of Alpha-1 Antitrypsin Deficiency
Kioxia Sampling UFS 5.0 Embedded Flash Memory Devices for Next-Generation Mobile Applications
Mobileum Showcases ¡°Signal to Value¡± at MWC Barcelona 2026
Samsung Bioepis Enters into Partnership Agreement with Sandoz for Up to Five Next-Generation Biosimilar Candidates
Angelini Pharma and Quiver Bioscience Partner on Strategic Collaboration and Licensing to Advance Novel Genetic Epilepsy Therapeutics

 

1NCE and Netmore Combine Cellular and LoRaWAN Access to Deliver Global...
Organon Enters into Agreement to License MIUDELLA¢ç, Sebela Pharmaceut...
Qualitative Shifts in DDoS Attack Sophistication, Infrastructure Capac...
AMWC 2026: Galderma Unveils Leading Innovation With Comprehensive Port...
Canoga Perkins and Druid Deliver FRER-Enabled Resilience for Mission-C...
Galderma Gains Triple Approval for New Restylane Syringe in EU, US, Ca...
LG Electronics To Unveil Advanced Compressor Solutions Engineered for ...

 


010¶óÀÎ
ÇØ´ç¼½¼Ç¿¡ ´º½º°¡ ¾ø½À´Ï´Ù

 

»ç¾÷¼Ò°³ | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö

±â»çÁ¦º¸ news@newsji.com, ÀüÈ­ 050-2042-2042, ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60, 1-37

´º½º±×·ì »ç¾÷µî·Ï ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12. 23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright, ´º½º±×·ì ÀÚµ¿Â÷°æÁ¦¿¬±¸¼Ò